Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity

初次接触流感对流感免疫的质量、程度、广度、效力和持久性的影响

基本信息

  • 批准号:
    10394227
  • 负责人:
  • 金额:
    $ 444.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-05-15 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY ABSTRACT A more universal vaccine against influenza virus infection is urgently needed. However, a major obstacle limiting more effective and durable vaccines against influenza infection stem from the rapidly shifting nature of viral immune dominant epitopes. Further confounding this obstacle are functional differences in the immunological responsiveness to vaccination and susceptibility of individuals to natural infection primed by prior exposure to influenza antigens. This type of immunological imprinting likely explains the wide discordance in effectiveness of current seasonal influenza vaccines. Considering the near ubiquitous exposure of individuals to influenza virus, together with the wide variability in clinical symptoms from asymptomatic to severe infection and increasingly widespread use of seasonal immunization, immunological imprinting to influenza virus is likely initiated during infancy with the first exposure to natural infection or immunization. Importantly, critical knowledge gaps remain regarding how individuals respond to primary influenza exposure in early life, in the context of natural infection or vaccination, and how a lack of pre-existing immunity effects within-host influenza viral diversity. It is also unclear how this first exposure to influenza impacts the subsequent immunological responsiveness to antigenically identical, similar or discordant influenza epitopes. For infants, the impact of vertically transferred maternal immunity, or that acquired postnatally through breastfeeding, on the quality of ensuing influenza specific immune responses remain unclear. To fill these knowledge gaps, ongoing recruitment of a maternal-infant cohort at Cincinnati Children’s Hospital will be expanded, along with parallel efforts in Mexico City. Both sites have ongoing surveillance providing additional cases of symptomatic primary infection. With the proposed enrollment of more than 2000 pregnant women, our two-site cohort is ideally suited for the proposed studies given our established infrastructure of weekly nasal swabs and symptom reporting, scheduled blood collection to detect asymptomatic and symptomatic influenza, maternal and cord blood and milk sample analyses and detailed evaluations of susceptibility and immunological responses to influenza infection and vaccination in mothers and infants. Our overall hypothesis is that primary influenza exposure in early life impacts the magnitude, durability and breadth of immunological memory to an evolving range of influenza virus antigens and this initial imprint will have a profound effect on subsequent influenza exposures. A team of investigators with complementary expertise in pediatric infectious diseases, epidemiology, maternal-infant cohorts, human B and T cell immunology and influenza virology have been assembled to address our hypothesis by investigating the immunological response of infants to primary influenza virus natural infection compared with immunization (Aim 1), compare the immunological response against an initial exposure to influenza virus via natural infection or immunization in infants (Aim 2), and investigating the impact of pre-existing influenza immunity on virus genetic diversity within individuals (Aim 3).
项目总结摘要 迫切需要一种更普遍的流感病毒感染疫苗。然而,一个主要的障碍是 限制针对流感感染的更有效和更持久的疫苗源于 病毒免疫优势表位。进一步混淆这一障碍的是 疫苗接种的免疫反应性和个体对自然感染的易感性 以前接触过流感抗原。这种类型的免疫印记很可能解释了广泛的不一致 目前季节性流感疫苗的有效性。考虑到几乎无处不在的曝光 个体对流感病毒的感染,以及临床症状从无症状到 严重感染和日益广泛使用的季节性免疫,免疫印记 流感病毒很可能是在婴儿首次接触自然感染或免疫时开始感染的。 重要的是,关于个人如何应对#年的初级流感暴露,关键的知识缺口仍然存在。 早期生命,在自然感染或接种疫苗的背景下,以及缺乏先前存在的免疫系统如何产生影响 宿主内流感病毒多样性。目前也不清楚首次接触流感会对 随后对抗原性相同、相似或不一致的流感表位的免疫应答。 对于婴儿,垂直转移的母体免疫的影响,或通过出生后获得的 母乳喂养对随之而来的流感的质量的特异性免疫反应仍不清楚。为了填满这些 知识差距,辛辛那提儿童医院正在进行的母婴队列招募工作将是 扩大了,同时在墨西哥城开展了类似的努力。这两个地点都有持续的监控,提供了更多 有症状的原发感染4例。随着2000多名孕妇的建议招生,我们的 考虑到我们每周鼻腔基础设施的建立,双部位队列非常适合拟议的研究 拭子和症状报告,定期采血以检测无症状和有症状的流感, 孕妇、脐带血和乳汁样本分析和详细评估 母婴对流感感染和疫苗接种的免疫学反应。我们的总体假设 早期接触原发流感会影响免疫学的大小、持久性和广度吗? 对一系列进化的流感病毒抗原的记忆和这一最初的印记将对 随后接触到流感。在儿科感染性疾病方面具有互补专业知识的调查团队 疾病、流行病学、母婴队列、人类B和T细胞免疫学以及流感病毒学 通过研究婴儿对初发疾病的免疫反应来验证我们的假设 流感病毒自然感染与免疫比较(目标1),比较免疫学反应 通过婴儿自然感染或免疫首次接触流感病毒(目标2);以及 调查先前存在的流感免疫对个体内病毒遗传多样性的影响(目标3)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY A STAAT其他文献

MARY A STAAT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY A STAAT', 18)}}的其他基金

US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
美国加强监测网络评估疫苗预防儿童肠道和呼吸道病毒的负担、自然史和有效性
  • 批准号:
    10347720
  • 财政年份:
    2021
  • 资助金额:
    $ 444.27万
  • 项目类别:
US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
美国加强监测网络评估疫苗预防儿童肠道和呼吸道病毒的负担、自然史和有效性
  • 批准号:
    10598645
  • 财政年份:
    2021
  • 资助金额:
    $ 444.27万
  • 项目类别:
IP21-002 US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
IP21-002 美国增强监测网络,评估预防儿童肠道和呼吸道病毒的疫苗负担、自然史和有效性
  • 批准号:
    10669091
  • 财政年份:
    2021
  • 资助金额:
    $ 444.27万
  • 项目类别:
COVID-19 Epidemiology and Immune-Pathogenesis in Pregnant Women, Mothers and Children
COVID-19 孕妇、母亲和儿童的流行病学和免疫发病机制
  • 批准号:
    10213945
  • 财政年份:
    2020
  • 资助金额:
    $ 444.27万
  • 项目类别:
Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity
初次接触流感对流感免疫的质量、程度、广度、效力和持久性的影响
  • 批准号:
    10614959
  • 财政年份:
    2019
  • 资助金额:
    $ 444.27万
  • 项目类别:
Impact of the Initial Influenza Exposure on the Quality, Magnitude, Breadth, Potency and Durability of Influenza Immunity
初次接触流感对流感免疫的质量、程度、广度、效力和持久性的影响
  • 批准号:
    9925182
  • 财政年份:
    2019
  • 资助金额:
    $ 444.27万
  • 项目类别:
COVID-19 Epidemiology and Immune-Pathogenesis in Pregnant Women, Mothers and Children
COVID-19 孕妇、母亲和儿童的流行病学和免疫发病机制
  • 批准号:
    10611603
  • 财政年份:
    2019
  • 资助金额:
    $ 444.27万
  • 项目类别:
COVID-19 Epidemiology and Immune-Pathogenesis in Pregnant Women, Mothers and Children
COVID-19 孕妇、母亲和儿童的流行病学和免疫发病机制
  • 批准号:
    10265666
  • 财政年份:
    2019
  • 资助金额:
    $ 444.27万
  • 项目类别:
Enhanced Surveillance for New Vaccine Preventable Diseases
加强对新疫苗可预防疾病的监测
  • 批准号:
    9206762
  • 财政年份:
    2016
  • 资助金额:
    $ 444.27万
  • 项目类别:
Enhanced Surveillance for New Vaccine Preventable Diseases
加强对新疫苗可预防疾病的监测
  • 批准号:
    9980742
  • 财政年份:
    2016
  • 资助金额:
    $ 444.27万
  • 项目类别:

相似海外基金

Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
  • 批准号:
    10574738
  • 财政年份:
    2023
  • 资助金额:
    $ 444.27万
  • 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
  • 批准号:
    10392870
  • 财政年份:
    2021
  • 资助金额:
    $ 444.27万
  • 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
  • 批准号:
    10092930
  • 财政年份:
    2020
  • 资助金额:
    $ 444.27万
  • 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
  • 批准号:
    9896170
  • 财政年份:
    2020
  • 资助金额:
    $ 444.27万
  • 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
  • 批准号:
    433456
  • 财政年份:
    2020
  • 资助金额:
    $ 444.27万
  • 项目类别:
    Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
  • 批准号:
    19K15765
  • 财政年份:
    2019
  • 资助金额:
    $ 444.27万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
  • 批准号:
    9932769
  • 财政年份:
    2018
  • 资助金额:
    $ 444.27万
  • 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
  • 批准号:
    BB/P504713/1
  • 财政年份:
    2017
  • 资助金额:
    $ 444.27万
  • 项目类别:
    Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
  • 批准号:
    1932904
  • 财政年份:
    2017
  • 资助金额:
    $ 444.27万
  • 项目类别:
    Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
  • 批准号:
    1632399
  • 财政年份:
    2016
  • 资助金额:
    $ 444.27万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了